BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34455229)

  • 1. Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant.
    Brédart A; De Pauw A; Anota A; Tüchler A; Dick J; Müller A; Kop JL; Rhiem K; Schmutzler R; Devilee P; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2021 Dec; 60():38-44. PubMed ID: 34455229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study.
    Brédart A; De Pauw A; Tüchler A; Lakeman IMM; Anota A; Rhiem K; Schmutzler R; van Asperen CJ; Devilee P; Stoppa-Lyonnet D; Kop JL; Dolbeault S
    Clin Genet; 2022 Jul; 102(1):30-39. PubMed ID: 35508697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.
    Vos J; Oosterwijk JC; Gomez-Garcia E; Menko FH; Collee MJ; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Patient Educ Couns; 2012 Feb; 86(2):239-51. PubMed ID: 21684708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A counselee-oriented perspective on risk communication in genetic counseling: explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure.
    Vos J; Stiggelbout AM; Oosterwijk J; Gomez-Garcia E; Menko F; Collee JM; van Asperen CJ; Tibben A
    Genet Med; 2011 Sep; 13(9):800-11. PubMed ID: 21885922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does and should breast cancer genetic counselling include lifestyle advice?
    Albada A; Vernooij M; van Osch L; Pijpe A; van Dulmen S; Ausems MG
    Fam Cancer; 2014 Mar; 13(1):35-44. PubMed ID: 23934600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial.
    Albada A; van Dulmen S; Bensing JM; Ausems MG
    Breast Cancer Res; 2012 Mar; 14(2):R37. PubMed ID: 22394647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.
    Albada A; van Dulmen S; Lindhout D; Bensing JM; Ausems MG
    Fam Cancer; 2012 Mar; 11(1):85-95. PubMed ID: 21901499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences.
    Pieterse AH; Ausems MG; Van Dulmen AM; Beemer FA; Bensing JM
    Am J Med Genet A; 2005 Aug; 137(1):27-35. PubMed ID: 16007615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study.
    Brédart A; Kop JL; Tüchler A; De Pauw A; Cano A; Dick J; Rhiem K; Devilee P; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S
    Eur J Hum Genet; 2022 Sep; 30(9):1067-1075. PubMed ID: 35399119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of counselee and counselor satisfaction in reproductive genetic counseling.
    Aalfs CM; Oort FJ; de Haes JC; Leschot NJ; Smets EM
    Clin Genet; 2007 Aug; 72(2):74-82. PubMed ID: 17661810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counselee participation in follow-up breast cancer genetic counselling visits and associations with achievement of the preferred role, cognitive outcomes, risk perception alignment and perceived personal control.
    Albada A; Ausems MG; van Dulmen S
    Soc Sci Med; 2014 Sep; 116():178-86. PubMed ID: 25016325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.
    Alter BP; Best AF
    Breast Cancer Res Treat; 2020 Jul; 182(2):465-476. PubMed ID: 32488392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
    Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
    Roshanai AH; Rosenquist R; Lampic C; Nordin K
    Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.
    Albada A; van Dulmen S; Dijkstra H; Wieffer I; Witkamp A; Ausems MG
    J Genet Couns; 2016 Apr; 25(2):279-89. PubMed ID: 26321750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.